These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36087422)

  • 1. Investigation of novel de novo KCNC2 variants causing severe developmental and early-onset epileptic encephalopathy.
    Li L; Liu Z; Yang H; Li Y; Zeng Q; Chen L; Liu Y; Chen Y; Zhu F; Cao D; Hu J; Shen X
    Seizure; 2022 Oct; 101():218-224. PubMed ID: 36087422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel KCNC2 variant associated with developmental and epileptic encephalopathy.
    Huo L; Wu Q; Yang F; Liu X; Yang Z; Wang H
    Int J Dev Neurosci; 2023 Jun; 83(4):357-367. PubMed ID: 37203270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recurrent de novo variant supports KCNC2 involvement in the pathogenesis of developmental and epileptic encephalopathy.
    Rydzanicz M; Zwoliński P; Gasperowicz P; Pollak A; Kostrzewa G; Walczak A; Konarzewska M; Płoski R
    Am J Med Genet A; 2021 Nov; 185(11):3384-3389. PubMed ID: 34448338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A structurally precise mechanism links an epilepsy-associated
    Clatot J; Currin CB; Liang Q; Pipatpolkai T; Massey SL; Helbig I; Delemotte L; Vogels TP; Covarrubias M; Goldberg EM
    Proc Natl Acad Sci U S A; 2024 Jan; 121(3):e2307776121. PubMed ID: 38194456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With
    Schwarz N; Seiffert S; Pendziwiat M; Rademacher AV; Brünger T; Hedrich UBS; Augustijn PB; Baier H; Bayat A; Bisulli F; Buono RJ; Bruria BZ; Doyle MG; Guerrini R; Heimer G; Iacomino M; Kearney H; Klein KM; Kousiappa I; Kunz WS; Lerche H; Licchetta L; Lohmann E; Minardi R; McDonald M; Montgomery S; Mulahasanovic L; Oegema R; Ortal B; Papacostas SS; Ragona F; Granata T; Reif PS; Rosenow F; Rothschild A; Scudieri P; Striano P; Tinuper P; Tanteles GA; Vetro A; Zahnert F; Goldberg EM; Zara F; Lal D; May P; Muhle H; Helbig I; Weber Y
    Neurology; 2022 May; 98(20):e2046-e2059. PubMed ID: 35314505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A de novo heterozygous mutation in KCNC2 gene implicated in severe developmental and epileptic encephalopathy.
    Vetri L; Calì F; Vinci M; Amato C; Roccella M; Granata T; Freri E; Solazzi R; Romano V; Elia M
    Eur J Med Genet; 2020 Apr; 63(4):103848. PubMed ID: 31972370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized structural biology reveals the molecular mechanisms underlying heterogeneous epileptic phenotypes caused by
    Mukherjee S; Cassini TA; Hu N; Yang T; Li B; Shen W; Moth CW; Rinker DC; Sheehan JH; Cogan JD; ; Newman JH; Hamid R; Macdonald RL; Roden DM; Meiler J; Kuenze G; Phillips JA; Capra JA
    HGG Adv; 2022 Oct; 3(4):100131. PubMed ID: 36035247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging evidence of genotype-phenotype associations of developmental and epileptic encephalopathy due to KCNC2 mutation: Identification of novel R405G.
    Wang S; Yu Y; Wang X; Deng X; Ma J; Liu Z; Gu W; Sun D
    Front Mol Neurosci; 2022; 15():950255. PubMed ID: 36090251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K
    Boddum K; Hougaard C; Xiao-Ying Lin J; von Schoubye NL; Jensen HS; Grunnet M; Jespersen T
    Neuropharmacology; 2017 May; 118():102-112. PubMed ID: 28242439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired fast-spiking, suppressed cortical inhibition, and increased susceptibility to seizures in mice lacking Kv3.2 K+ channel proteins.
    Lau D; Vega-Saenz de Miera EC; Contreras D; Ozaita A; Harvey M; Chow A; Noebels JL; Paylor R; Morgan JI; Leonard CS; Rudy B
    J Neurosci; 2000 Dec; 20(24):9071-85. PubMed ID: 11124984
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Seiffert S; Pendziwiat M; Hedrich UBS; Helbig I; Weber Y; Schwarz N
    Front Neurol; 2023; 14():1212079. PubMed ID: 37360341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kv3 potassium conductance is necessary and kinetically optimized for high-frequency action potential generation in hippocampal interneurons.
    Lien CC; Jonas P
    J Neurosci; 2003 Mar; 23(6):2058-68. PubMed ID: 12657664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of specific K(+) channels in sustained high-frequency firing of fast-spiking neocortical interneurons.
    Erisir A; Lau D; Rudy B; Leonard CS
    J Neurophysiol; 1999 Nov; 82(5):2476-89. PubMed ID: 10561420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A KCNC1-related neurological disorder due to gain of Kv3.1 function.
    Clatot J; Ginn N; Costain G; Goldberg EM
    Ann Clin Transl Neurol; 2023 Jan; 10(1):111-117. PubMed ID: 36419348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional effects of spinocerebellar ataxia type 13 mutations are conserved in zebrafish Kv3.3 channels.
    Mock AF; Richardson JL; Hsieh JY; Rinetti G; Papazian DM
    BMC Neurosci; 2010 Aug; 11():99. PubMed ID: 20712895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of Kv3.1b expression in avian auditory brainstem neurons correlates with synaptogenesis in vivo and in vitro.
    Kuenzel T; Wirth MJ; Luksch H; Wagner H; Mey J
    Brain Res; 2009 Dec; 1302():64-75. PubMed ID: 19766604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and molecular differences between voltage-gated K+ channels of fast-spiking interneurons and pyramidal neurons of rat hippocampus.
    Martina M; Schultz JH; Ehmke H; Monyer H; Jonas P
    J Neurosci; 1998 Oct; 18(20):8111-25. PubMed ID: 9763458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Casein kinase 2 determines the voltage dependence of the Kv3.1 channel in auditory neurons and transfected cells.
    Macica CM; Kaczmarek LK
    J Neurosci; 2001 Feb; 21(4):1160-8. PubMed ID: 11160386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mosaicism of a missense variant in KCNC2 in a multiplex family with autism and epilepsy characterized by long-read sequencing.
    Mehinovic E; Gray T; Campbell M; Ekholm J; Wenger A; Rowell W; Grudo A; Grimwood J; Korlach J; Gurnett C; Constantino JN; Turner TN
    Am J Med Genet A; 2022 Jul; 188(7):2071-2081. PubMed ID: 35366058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical characterization of KV3.1 potassium channel activating compounds.
    Taskin B; von Schoubye NL; Sheykhzade M; Bastlund JF; Grunnet M; Jespersen T
    Eur J Pharmacol; 2015 Jul; 758():164-70. PubMed ID: 25845309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.